industry pr

Press release news from the public relations clients of Tiziani Whitmyre, Inc.

Health/Medical Newsfeed


Thursday, November 20th, 2014

New EH&E Inc. Program Improves Fire & Life Safety Compliance During & After Construction at Hospitals

EH&E LogoNeedham, Mass., November 20, 2014 — EH&E, a leading provider of risk management, environmental and engineering consulting services, has introduced a new inspection service that assists hospitals to improve firestopping and life safety compliance during and after construction projects.

Construction, renovation, maintenance, and tele-data upgrades are constant at hospitals. The complexity and pace of these projects can lead to unexpected compromises in firewall barriers — creating both compliance problems and safety issues.

EH&E’s new Firestopping and Life Safety Management program, designed in conjunction with Brigham and Women’s Hospital (BWH), shows hospitals how to cost effectively resolve construction-related compliance deficiencies and set the foundation for maintaining life safety and firewall barrier systems throughout the life of their buildings.

By addressing the root causes of firewall breaches and enabling the proactive identification and resolution of fire and life safety deficiencies during construction, the hospital starts with a safe and compliant building at the time of occupation. The hospital saves costs because rather than inheriting fire safety deficiencies from construction, the responsibility for repairs is placed with the contractor. In addition, the program’s “continuous compliance” focus ensures that proper procedures will be followed during ongoing maintenance and future renovations. Field inspectors utilize mobile devices to note conditions and provide photographic documentation that is instantly uploaded to a secure website for real-time notification to the contractors followed by auto-tracking of resolution, acceptance and record keeping.

At BWH, program results included greater than 96% compliance with The Joint Commission, and an estimated savings of more than $1 per square foot of floor area through the repair of firewall deficiencies prior to occupancy.

This summer, the program won the 2014 IFMA Boston Excellence Award for Best Practices in Sustainability, honored for setting “a new benchmark” and establishing “a model of best practices.”

For more information on EH&E’s new Firestopping and Life Safety Management program, or to download a case study detailing the BWH project, visit http://www.eheinc.com/firesafety_hospital_wp.htm.

About EH&E

EH&E (http://www.eheinc.com) has provided an extensive range of risk management, environmental and engineering consulting services for over 25 years. Our team consists of more than 60 experts with an outstanding record of providing business-focused solutions for issues that affect the built environment. Our focus on “evidence-based decision making” and advanced capabilities in analytics and technology innovation enables clientsto achieve and quantify optimal performance from their people and assets. EH&E is the partner of choice for reduced organizational risk, improved business outcomes, faster time to problem resolution and greater stakeholder satisfaction.


Wednesday, November 12th, 2014

Available Time to Train Staff, Certifications to Ship Hazardous Materials are Top Challenges Facing Hospitals in Ebola Preparedness, States EH&E Survey

Needham, Mass. — Nov. 12, 2014 — The lack of available time to train staff, and uncertainties about certifications to ship infectious substances, are the top challenges facing hospitals undertaking Ebola preparedness and safety precautions, according to a recently conducted survey by EH&E, Inc., a leading provider of environmental and engineering consulting services.

“Nearly half (48%) of the hospitals responding to the survey stated that ‘available time for patient care staff’ was the most important limitation in providing hands-on Ebola virus disease training to clinical staff, including hands-on PPE donning/doffing procedures,” according to Bryan Connors, MS, CIH, Healthcare Practice Director, EH&E.

Another 20% cited money or lack of qualified staff and internal resources to support training as their key limitation.

EH&E surveyed hospital environmental health and safety (EHS) managers, risk managers, and facilities mangers in 41 U.S. hospitals. The “EH&E Hospital Ebola Preparedness Surveyfocused on issues relating to personal protective equipment (PPE) training, Ebola-specific training, and hazardous waste management. The survey was conducted in late October.

“EH&E recommends selecting a small number of staff to be highly trained in Ebola preparedness and safety precautions. This group may include a select number of nurses, physicians, respiratory therapists, ‘safety monitors,’ and environmental services staff to participate in initial and periodic retraining sessions, including PPE donning and doffing procedures,” said Bryan Connors, MS, CIH, Senior Scientist and Healthcare Division Practice Leader, EH&E, Inc.

“The ‘safety monitor’ role is critical to staff safety, which works like a ‘Buddy System’ assuring front line clinical staff don and doff PPE appropriately and any safety issues are addressed in real time,” Connors noted.

“Of course, the strategy on how many staff to train will be dependent on many factors, including the type and size of the hospital,” he added.

The survey also identified a potential vulnerability in preparedness as more than half (55%) of hospitals reported not having or not knowing if they have staff trained to ship Category A Infectious Substances per IATA and DOT — such as patient specimens being sent for Ebola diagnosis or that are confirmed positive for Ebola.

“Workflow planning and procedures for Category A Infectious Substances shipments must be in place well in advance of their need,” said Connors. “This type of training can take upwards of eight hours to complete and must be properly documented. In practice, ‘on demand’ training is simply not an option.”

Overall, an overwhelming majority of hospitals reported meeting (76%) or exceeding (12%) CDC guidelines, with 12% replying they had not yet met requirements.

Nearly two-thirds (64%) of hospitals in the survey reported that they are actively conducting Ebola training, including specific PPE training. The reminder had either conducted training for other infectious diseases (21%) or training in Ebola preparedness but without training on specific PPE donning and doffing procedures (10%). Just 5% of hospitals reported not conducting Ebola specific training to date — at least as of October 21.

“It is highly likely that while training has increased in all categories since the survey was taken — the challenges remain as hospitals work to ensure not only the quality of care for patients, but the safety and well-being of caregivers and the public,” Connors noted.

A summary of the survey results, “EH&E Hospital Ebola Preparedness: Survey Results,” is available to download from http://www.eheinc.com/ebola_survey.htm.  Details are available by request by contacting Bryan Connors by phone 1-800-825-5343 or email contact@eheinc.com.

About EH&E

EH&E (http://www.eheinc.com) has provided an extensive range of environmental and engineering consulting services for over 25 years. Our team consists of more than 60 experts with an outstanding record of providing business-focused solutions for issues that affect the built environment. EH&E has a depth of knowledge and credibility unmatched in the industry and our wealth of readily-accessible information has become a powerful resource for our clients.


Thursday, July 24th, 2014

ASCO Introduces 068 Series Flapper Isolation Valve; Improves Throughput, Reduces Sample Size in Clinical and Analytical Instruments

ASCO 068 Series Flapper Isolation Valve-01FLORHAM PARK, N.J., July 24, 2014 — ASCO Numatics has introduced its 16mm ASCO 068 Series flapper isolation solenoid valve, the first in its class with technology that offers greater throughput, smaller sample sizes, and reduced calibration requirements for clinical and analytical instruments.

“Our new ASCO 068 Series valve’s 20 ms response time and exceptional volume control mean original equipment manufacturers (OEMs) can design instruments with higher productivity, better flushability, and more precise measurements,” said Robert W. Kemple, Jr., executive vice president, sales and marketing – Americas, ASCO Numatics. “End users will benefit from much greater measurement repeatability, smaller sample and reagent requirements, and reduced calibration frequency.”

The ASCO 068 Series valve is ideal for OEMs serving the clinical diagnostic, life science, sterilization, and dental markets.

The valve is designed for use with neutral and aggressive liquids and gases. Its flapper technology allows high pressures to be achieved (up to 116 psi) at large orifice sizes while preventing the fluid contamination that can result from spikes in back pressure inherent in analytical devices. The highly reliable valve has been tested to well over 10 million cycles for extended product life.

The solenoid isolation valve also features:

  • Excellent operating characteristics under vacuum conditions
  • Low pumping effects
  • Self-draining capability and easy-to-flush internal cavity
  • Low heat transfer between control mechanism and media
  • Optional onboard power saver mode

In isolation valves, hermetic separation of the control mechanism and fluid prevents particulate contamination caused by friction of the mechanical components. This ensures maximum purity of the fluids or gases in all isolation applications.

ASCO’s 068 Series valves can be ordered as a turnkey fluid automation solution that includes a manifold with fittings and special connections. “These plug-and-play assemblies provide OEM’s with lower manufacturing costs and faster production cycles,” said Kemple. “Our valves were specifically designed for use in hematology, oncology, chromatography, chemical sterilization, water quality monitoring, DNA sequencing, and liquid-handling equipment applications.”

The 068 Series valves are available through the ASCO Today same-day shipping program and can be ordered through ASCO distributors and sales representatives. For more information, contact ASCO at 800-972-ASCO (2726), by e-mail at info-valve@ascovalve.com, or visit www.ascovalve.com/068.

About ASCO Numatics

ASCO Numatics, an Emerson company, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit www.asconumatics.com.

About Emerson and Emerson Industrial Automation

Emerson (www.Emerson.com) is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world. The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2013 were $24.7 billion. Emerson Industrial Automation (www.EmersonIndustrial.com), a business of Emerson, provides automation and power generation technologies and services to a wide range of industries. With its global capabilities and deep industry expertise, Emerson Industrial Automation is a trusted partner for products and solutions that increase machine performance, efficiency, reliability, and availability. Its industry-leading brands include Appleton®, ASCO®, Branson®, Browning®, Control Techniques, Kop-Flex®, Leroy-Somer®, McGill®, Morse®, Numatics®, O-Z/Gedney, Rollway®, SealMaster®, and System Plast™.

 

Press Contacts: Don Goncalves, 781-793-9380, dgoncalves@tizinc.com


Monday, July 21st, 2014

NoInjuries.com Offers Free Support Kit to Help Prevent Healthcare Injuries to Caregivers, Patients

photo_kitLehigh Valley, Penn. – July 21, 2014 — The non-profit NoInjuries.com initiative is offering a free support kit to help prevent healthcare injuries to both caregivers and patients. The kit, which contains useful tools and tips for implementing and sustaining a facility-wide healthcare injuries prevention program, is available to download at http://www.noinjuries.com/resources/facility-support-kit.

“Healthcare is the largest and fastest-growing sector of the U.S. economy, employing approximately 17 million workers,” said Hans Sigvardsson, president of Handicare US. “Safety must be a priority on all fronts.”

Developed by Handicare US, “the NoInjuries.com initiative was launched to help stem the growing number of healthcare injuries — the vast majority of which are preventable,” he said. “Our goals is to make ‘no injuries’ a reality for patients, caregivers, and others.”

The NoInjuries.com “Facility Support Kit” includes handy assessment guides for conducting a facility self-assessment, helpful hints on organizing a team, changing the workplace culture, an early patient mobility guide — and ongoing updates.

The kit is one element of the NoInjuries.com initiative, Sigvardsson noted. Noinjuries.com features up-to-date news, educational materials, easy-to-implement tips, and tools and resources to use throughout the workplace. Six critical hazard areas are spotlighted: Patient Handling; Sharps & Sticks; Infections; Slips & Falls; Workplace Violence; and Patient Safety.

Download the NoInjuries.com “Facility Support Kit” kit at http://www.noinjuries.com/resources/facility-support-kit. For more information about the NoInjuries.com initiative on preventing healthcare injuries, visit the NoInjuries.com website at http://www.NoInjuries.com.

About Handicare 

Handicare was founded in 1986 and supplies safe handling and mobility solutions for hospital patients, elderly residents, and physically disabled individuals. Its products include wheelchairs, patient lifts, stairlifts, mobility equipment, bathroom safety products, and personal transfer and automobile adaptation solutions. Handicare products are distributed through a comprehensive network of professional dealers and distributors in 30 countries around the world. The company has subsidiaries in Sweden, Denmark, Germany, the Netherlands, England, Belgium, France, the USA, and Canada. For more information, visit the Handicare website at http://www.handicare.com.

About Handicare North America

Handicare NA is headquartered in Allentown, Pennsylvania, and works with over 400 partners in North America to provide Safe Patient Handling, Mobility and Accessibility equipment to people with disabilities, aging and elderly individuals residing at home or in hospitals and nursing homes. With significant growth over the past year, Handicare US is well positioned to assume leadership roles in safe patient handling and improved patient outcomes, both of which are areas of strategic concern for healthcare administrators and caregivers.

The company’s wide range of high-quality products include: Complete easy transfer systems and other patient handling aids, walkers, stairlifts, and bathing and toileting products. In 2012, RoMedic, Inc. (Ephrata, PA) and Sterling Stairlifts (Pocono Mountain, PA) merged to form the Handicare NA and provide solutions and support that allow people to work and live safely and independently.


Tuesday, June 17th, 2014

Fish Embryo Toxicology Testing is Better Alternative for Whole-Effluent Testing, Advises New Whitepaper from Microtest Laboratories

AGAWAM, MASS. – June 17, 2014 – As pharmaceutical, chemical and other manufacturers come under increased scrutiny for their Whole Effluent Toxicity (WET), a new methodology to measure WET — fish embryo toxicity (FET) testing — promises to better determine the potential environmental impact of their products and waste water on the environment.

Developed for environmental and hazard classification applications, FET testing provides many advantages in the testing of pharmaceuticals, chemicals, and pesticides — from their application in the field to their impact in sewage and water runoff from manufacturing facilities.

A new whitepaper titled Fish Embryo Toxicology Testing: The Better Alternative for Whole-Effluent Testing discusses FET testing, how it works, and its benefits. The paper is available for download at http://microtestlabs.com/fish-embryo-toxicology-testing from Microtest Laboratories.

FET testing utilizes the embryo of the Zebrafish and exposes it to various compounds to observe potential toxic effects, thus making the test ideal for use in monitoring or investigating environmental cases. FET is an approved OECD (Organization for Economic Co-Operative Development) guideline published in 2013.

Microtest Laboratories is deeply experienced in providing fish embryo toxicity testing, due to the expertise the company developed from creating its own Zebrafish Embryo Toxicity (ZET) test, which it provides as a preliminary screening method in the biocompatibility testing of medical devices and polymers.

For details on the benefits of FET testing, download the whitepaper, “Fish Embryo Toxicology Testing is the better alternative for whole-effluent testing,” from: http://microtestlabs.com/fish-embryo-toxicology-testing. For information on FET testing services from Microtest Laboratories, visit http://www.microtestlabs.com/zebrafish-embryos-testing, or call 1-413-786-1680, or toll-free 1-800-631-1680.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://microtestlabs.com or call 1-413-786-1680 or toll-free at 1-800-631-1680. Follow Microtest Laboratories on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.


Monday, May 19th, 2014

Fundamentals of Endotoxin Testing for Medical Device Manufacturers are Detailed in New Technical Brief

AGAWAM, MASS. — May 19, 2014 — The fundamentals of endotoxin testing for medical device manufacturers — from definition to assay acceptance criteria —are detailed in new technical brief available from Microtest Laboratories.

Bacterial endotoxins cause fever, septic shock, and other disease symptoms — and thus attract considerable regulatory scrutiny from such organizations as the U.S. Food & Drug Administration (FDA) and the United States Pharmacopeial Convention. Regulations require that devices that contact circulating blood or cerebrospinal fluid, or are used with intraocular products or in vitro fertilization procedures, are required to be endotoxin-free.

The Fundamentals of Endotoxin Testing,” available for download at http://microtestlabs.com/endotoxin-testing, is a step-by-step information resource for medical device manufacturers discussing and detailing the:

  • Definition of endotoxins;
  • Various tests used for their detection;
  • Use of depyrogenation and other ways to remove endotoxins;
  • Types of devices that should be tested;
  • Preparation and testing of samples;
  • Options for sampling containers;
  • Acceptance criteria for each of the assays; and
  • Sources of official information, reference, and guidance.

The Fundamentals of Endotoxin Testing” is authored by Steven Richter, Ph.D., said Steven Richter, Ph.D., president and scientific director of Microtest Laboratories — and a former FDA official.

Download the brief from: http://microtestlabs.com/endotoxin-testing.

The paper is one in a series about testing, manufacturing, and regulatory issues of concern for medical device manufacturers from Microtest Laboratories, a leader in testing services and contract manufacturing for medical devices, pharmaceuticals, and biotechnology.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services and contract manufacturing for medical devices, pharmaceuticals, and biotechnology. It was founded in 1984. The company’s expertise and flexible processes enhance product safety and security, speed time to market, and minimize supply chain disruption. Microtest’s unique single-source capability to provide testing and manufacturing solutions allows the firm to support a full pharmaceutical or medical device product release. The company’s facilities in Agawam, Massachusetts, USA include state-of-the-art aseptic manufacturing areas; analytical chemistry, microbiological, and virological laboratories; Class 100 clean rooms; onsite steam and ethylene oxide sterilization, plus depyrogenation capabilities; purified water systems; and voice/data systems. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Twitter @MicrotestLabs on Facebook at http://goo.gl/TndoBg.


Monday, May 12th, 2014

Disinfectant Qualifications in Pharmaceutical Manufacturing Environments is Focus of White Paper

AGAWAM, MASS. – May 12, 2014 – A white paper outlining the six steps that pharmaceutical and medical device manufacturers must employ to qualify disinfectants used in their environmental cleaning processes is available from Microtest Laboratories. It is available for download from http://microtestlabs.com/6stepspaper-disinfectant-qualification.

“Sterile pharmaceutical and medical device manufacturing environments require an effective cleaning and disinfection program to maintain aseptic conditions and prevent the microbial contamination of the product. The qualification of the chemical disinfectants used in these environments is extremely important, yet it is often overlooked,” stated Deborah Ensign, supervisor, R&D of Microtest Laboratories, in the new white paper, “Six Steps to Qualifying Disinfectants.”

In fact, “disinfectant qualifications require more planning, time, and resources than many companies realize,” she said.

“Any time a new disinfectant is introduced into the cleaning process within the facility, a qualification should be performed. From start to finish, a disinfectant qualification can require from 2 to 12 months.

“The timeline for a disinfectant qualification will depend on a number of variables, including the number of disinfectants and challenge organisms being tested as well as the number of surfaces (for the coupon method) being evaluated,” Ensign noted.

“The bottom line is that no matter whether the disinfectant qualification is performed internally — or by an outside testing laboratory — these six steps must be addressed,” she warned.

Download a free copy of the white paper, “Six Steps to Qualifying Disinfectants” for pharmaceutical manufacturing companies from http://microtestlabs.com/6stepspaper-disinfectant-qualification.

Deborah Ensign is supervisor, R&D Lab, at Microtest Laboratories Inc. She has over 20 years of experience in regulatory microbiology and contract laboratory operations. Ms. Ensign supervises Microtest’s Specialized Microbiology department. She holds a bachelor of arts degree in microbiology and is a nationally registered microbiologist. Ms. Ensign oversees all reusable testing (cleaning, disinfecting, and sterilization) and serves as a resource for USP testing, specifically <51>, <61>, and <62>.

About Microtest Laboratories

Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, U.S.A., the company’s expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680.


Saturday, April 26th, 2014

Parenteral Drug Association to Discuss Rapid Micro Systems and Tour Microtest Laboratories on May 6th in Agawam, Mass.

AGAWAM, MASS. — April 28, 2014 — The New England Chapter of the Parenteral Drug Association (PDA) will feature “Rapid Micro Systems: A New Tool in Navigating the Stormy Seas of Biological Testing” at a May 6 meeting in Agawam, Mass. The meeting also will include a tour of Microtest Laboratories, a leading provider of life science testing services for pharmaceutical and medical device companies.

Keynote speakers at the meeting will include the following:

Dr. Bradford O. Fanger, Ph.D., field applications scientist at Azbil BioVigilant, will discuss “Reducing Manufacturing Risk with Rapid Microbiological Methods.” In his presentation, Dr. Fanger will provide an overview of rapid microbiological systems, the different types available, and their advantages.

James Gebo, senior research and development scientist, Microtest Laboratories, will review “Evaluation and Implementation of Rapid Microbiological Methods.” His presentation will explore the applications for rapid microbiological systems, review the business case for purchasing the technology, and explain ROI reporting.

The dinner meeting will be held at Kaptain Jimmy’s Restaurant and Distillery, 916 Suffield Street, Agawam. The Microtest tour will leave the restaurant at 4 p.m. Both PDA members and non-members are invited to attend.

To register, visit https://store.pda.org/Meetings/Login.aspx?ID=2273.

About the Parenteral Drug Association

The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. The New England Chapter was formed in 1988, and represents PDA members from the six New England states: Massachusetts, New Hampshire, Rhode Island, Vermont, Maine, and Connecticut.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Facebook at http://facebook.com/MicrotestLaboratories, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.


Tuesday, March 11th, 2014

Webinar Exploring “What’s the Risk? Fearing the Failure in Environmental Monitoring Systems” is Offered for Life Science Companies

AGAWAM, MASS. — March 11, 2014 — A webinar to help life science companies explore the importance of a well-implemented and understood environmental monitoring program, and its ability to generate valuable data, will be offered on Wednesday, March 26, from 1:30 p.m. to 3:30 p.m. EST. The online event will identify the common mistakes and misconceptions regularly encountered when managers “fear the failure” of environmental excursions.

Environmental monitoring systems demonstrate that a company’s various contamination control strategies are operating properly. Such systems can illustrate whether operations are in a state of control. Variations in the data can indicate a drift which could potentially impact product and patient safety.

But the data generated by environmental monitoring system may become skewed when a culture is created which fears environmental failures or excursions. The webinar, What’s the Risk? Fearing the Failure in Environmental Monitoring Systems,” will detail how key life science company management can work to avoid such cultures.

Webinar topics — tailored for quality assurance and control, manufacturing, microbiology, and facilities management in pharmaceutical, biotech, and medical device organizations — will include:

  • The big picture: what systems need to be monitored and why the data is valuable
  • Risk-based environmental monitoring program implementation
  • Culture and “buy-in:” how to create a culture of employee acceptance for contamination control programs
  • Responding to data: how to identify trends in the data and respond with appropriate actions

The webinar will be offered Wednesday, March 26, 1:30 p.m. to 3:30 p.m. EST. Featured speakers include Valerie Montgomery, environmental services manager, and Alison Zulick, environmental services leader, both of Microtest Laboratories, a leading provider of testing services and contract manufacturing for the life science industries.

To register or for more information about the webinar, What’s the Risk? Fearing the Failure in Environmental Monitoring Systems,” visit http://www.microrite.com/training/environmental-monitoring-systems-fearing-the-failure.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and compounding pharmacy industries. Based in Agawam, Massachusetts, USA, Microtest leverages its 30 years industry experience to help its clients meet their regulatory requirements.  For more information, visit http://www.microtestlabs.com or toll-free 1-800-631-1680.

 

# # #

Press contact: Don Goncalves, 1-781-793-9380, dgoncalves@tizinc.com


Tuesday, February 4th, 2014

Gordon Hempton to Receive National Hearing Conservation Association’s Media Award

Westminster, CO February 4, 2014 — Gordon Hempton, an acoustic ecologist with a passion for the pursuit of quiet places, will be presented with the National Hearing Conservation Association’s Media Award in Las Vegas in March, 2014.

The NHCA Media Award recognizes the efforts of writers and/or producers of news features that serve to heighten public awareness of the hazards of noise. The NHCA honors Gordon Hempton for his interview with Krista Tippet entitled “The Last Quiet Places.” It was first broadcast July 4, 2013, on Krista Tippet’s show, On Being, which is broadcast on National Public Radio. In the interview, Gordon takes listeners on a soundscape journey as he argues that silence, far from being a luxury, is an essential requirement of a full life, that it is an endangered species, and that quiet is the think tank of the soul. The interview can be downloaded or podcast by visiting http://www.onbeing.org/program/last-quiet-places/4557

Mr. Hempton has circled the globe three times in pursuit of the Earth’s rarest natural sounds. His sound portraits that record quickly vanishing natural soundscapes have been featured in People magazine and a national PBS television documentary, Vanishing Dawn Chorus, which earned him an Emmy. He provides professional audio services to media producers, including Microsoft, Smithsonian, National Geographic, and Discovery Channel. Recipient of awards from the National Endowment for the Arts and the Rolex Awards for Enterprise, he is co-author of One Square Inch of Silence: One Man’s Quest to Preserve Quiet (Free Press/Simon & Schuster, 2010).

The NHCA’s presentation of the Media Award to Gordon Hempton will take place at an awards luncheon during the NHCA’s 39th Annual Conference, to be held March 13-15, 2014, in Las Vegas, Nevada. For more information about the NHCA Conference, “Stop Gambling With Your Hearing,” go to http://www.hearingconservation.org.

About the National Hearing Conservation Association (NHCA)

The mission of the NHCA is to prevent hearing loss due to noise and other environmental factors in all sectors of society. NHCA’s membership includes audiologists, researchers, industrial hygienists, physicians and occupational health nurses, educators, professional service organizations, safety professionals, engineers, audio professionals, students, and others who have dedicated their work to the advancement of hearing loss prevention.

Visit the NHCA online at http://www.hearingconservation.org or call 1-303-224-9022. Follow the NHCA on Twitter at http://twitter.com/nhcaorg, on Facebook at http://bit.ly/vLRg5, and on LinkedIn at http://bit.ly/3X2DfT.


B2B News is proudly powered by WordPress.
WordPress